Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Can, Sukran
- OXA Carbapenemase Genes in Multidrug-resistant A. baumannii Strains in Southeast of Turkey
Abstract Views :271 |
PDF Views:105
Authors
Affiliations
1 Department of Medical Microbiology, Dicle University, TR
2 Department of Medical Microbiology, Yildirim Beyazit University, TR
3 Laboratory of Microbiology, Diyarbakir, Ergani State Hospital, TR
4 Department of Medical Microbiology, Selahaddin Eyyubi University, TR
1 Department of Medical Microbiology, Dicle University, TR
2 Department of Medical Microbiology, Yildirim Beyazit University, TR
3 Laboratory of Microbiology, Diyarbakir, Ergani State Hospital, TR
4 Department of Medical Microbiology, Selahaddin Eyyubi University, TR
Source
SMU Medical Journal, Vol 2, No 2 (2015), Pagination: 21-32Abstract
Increasing carbapenem resistance led to difficulties in treatment of multidrug-resistant (MDR) A. baumannii infections. We aimed to investigate the carbapenemase genes in MDR A.baumanii isolates. A total of 80 MDR A. baumannii strains were studied by multiplex PCR with the hyplex® CarbOxa ID test system. It involves amplification of blaOXA-51-like, blaOXA-23- like, blaOXA-40-like and blaOXA-58-likegene families and hybridisation of the PCR products to specific oligonucleotide probes in an ELISA-based system.All isolates were resistant against imipenem and meropenem while susceptible to colistin. The the intrinsic gene of A. baumannii was detected from 77 (96.25% ) strains. The presence of blaOXA 23-like, blaOXA 58-like and blaOXA 40-like genes were demonstrated in 48 (60%), 12 (15%), and 8 (10%) isolates, respectively. The blaOXA-23 - like was a common gene and colistin was a rare option for treatment of MDR A. baumannii infections in southeast of Turkey.
Keywords
MDR A. baumannii, Hyplex CarbOxa ID, blaOXA-23-like, blaOXA-40-like and blaOXA-58-like.Full Text
References
- Peleg, A.-Y., Seifert, H. and Paterson, D.-L. (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582.
- Higgins, P.-G., Dammhayn, C., Hackel, M., et al.(2010) Global spread of carbapenem resistant Acinetobacter baumannii. J.Antimicrob. Chemother. 65, 233-238.
- Afzal-Shah, M., Woodford, N. and Livermore, D.-M. (2001) Characterization of OXA-25, OXA-26 and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45, 583-588.
- Munoz-Price, L.-S. and Weinstein, R.-A.(2008) Acinetobacter infection. N. Engl. J. Med. 358, 1271-128.
- Haeritier, C., Poirel, L., Lambert, T., et al. (2005) Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49, 3198-3202.
- Walther-Rasmussen, J. and Hoiby, N. (2006) OXA-type carbapenemases. J. Antimicrob. Chemother. 57, 373-383.
- Poirel, L., Naas, T. and Nordmann, P. (2010) Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob. Agents Chemother. 54, 24-38.
- Higgins, P.-G., Perez-Llarena, F.-J., Zander, E., et al. (2013) OXA-235, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 57(5), 2121-2126.
- Naas, T. and Nordmann, P. (1999) OXA-type beta-lactamases. Curr. Pharm. Des. 5, 865-879.
- Horan, T.C., Andrus, M., Dudeck M.A.. (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 36, 309-332.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. (2011) CLSI M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute.
- Jones, R.N., Ferraro, M.J., Reler, L.B., et al. (2007) Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol. 45(1), 227-230.
- Tekin, R., Yolbas, I., Dal, T., Okur, M.H., Selçuk, C.T. (2013) The evaluation of patients with burns during fifteen years period. Clin Ter. 164(5), 385-389.
- Deveci, O., Dal, T., Tekin, R., Bozkurt, F., Tekin, A., Dayan, S. (2013) Carbapenem resistance in Acinetobacter baumannii: where is it heading? Infez Med. 21(3), 211-215.
- Dal, T., Aksu, B., Pagès, J-M., Over-Hasdemir, U.(2013) Expression of the adeB gene and responsiveness to 1-(1-naphthylmethyl)-piperazine and phenylalanyl-arginyl-β-naphthylamide in clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother. 68(5), 1200-1202.
- Cicek, A.C., Saral, A., Iraz, M., Ceylan, A., Duzgun, A.O., Peleg, A.Y., et al. (2014) OXA- and GES-type -β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect. 20(5), 410-415.
- Ergin, A., Hascelik, G., Eser, O.K. (2013) Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010. Scand J Infect Dis. 45(1), 26-31.
- Hasan, B., Perveen, K., Olsen, B., Zahra, R. (2014) Emergence of Carbapenem resistant Acinetobacter baumannii in the hospitals from Pakistan. J Med Microbiol. 63, 50-55.
- Vranic-Ladavac, M., Bedenic, B., Minandri, F., Istok, M., Bosnjak, Z., FranculaZaninovic, S., et al. (2014) Carbapenem resistance and acquired class D betalactamases in Acinetobacter baumannii from Croatia 2009-2010. Eur J Clin Microbiol Infect Dis. 33(3), 471-478.
- Dai, W., Huang, S., Sun, S., Cao, J., Zhang, L.(2013) Nosocomial spread of carbapenem-resistant Acinetobacter baumannii (types ST75 and ST137) carrying blaOXA-23-like gene with an upstream ISAba1 in a Chinese hospital. Infect Genet Evol. 14, 98-101.
- Chen, Z., Liu, W., Zhang, Y., Li, Y., Jian, Z., Deng, H., et al. (2013) Molecular epidemiology of carbapenem-resistant Acinetobacter spp. from XiangYa Hospital, in Hunan Province, China. J Basic Microbiol. 53(2), 121-127.
- Lee, M-H., Chen, T-L., Lee, Y-T., Huang, L., Kuo, S-C., Yu, K-W., et al. (2013) Dissemination of multidrug-resistant Acinetobacter baumannii carrying Bla(OxA-23) from hospitals in central Taiwan. J Microbiol Immunol Infect. 46(6), 419-424.
- Nowak, P., Paluchowska, P., Budak, A. (2012) Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol. 35(3), 317-325.
- Tiwari, V., Kapil, A., Moganty, R.R. (2002) Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microb Pathog. 53(2), 81-86.
- Sohrabi, N., Farajnia, S., Akhi, M.T., Nahaei, M.R., Naghili, B., Peymani, A., et al. (2012) Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist. 18(4), 385-389.
- Sari, A.N., Biçmen, M., Gulay, Z. (2013) The first report on the outbreak of OXA24/40-like carbapenemase-producing Acinetobacter baumannii in Turkey. Jpn J Infect Dis. 66(5), 439-442.